The peripheral blood lymphocyte response of patients with ankylosing spondylitis (AS) to several polyclonal B cell activators was investigated. No differences were found in the reactivity to pokeweed mitogen and protein A between patients and controls; in contrast, the peripheral blood lymphocyte response to Staphylococcus aureus strain Cowan I (SAC) was significantly higher in patients with AS than in controls. This responsiveness was not influenced either by the presence of the HLA-B27 antigen or by environmental factors or associated diseases, and it was higher in patients with active AS than in those with inactive disease. The percentage of circulating B celis was normal. The responses to T celi mitogens and the percentages of T celi subpopulations were similar in patients and in controls. The peripheral blood lymphocyte hyperactivity of patients with AS to SAC was associated with an increased in vitro production of immunoglobulins.
Despite its close association with HLA-B27 of the major histocompatibility complex, ankylosing spondylitis (AS) remains a disease of unknown cause. It has been suggested by two different groups of researchers that Klebsiella pneumoniae may have a role in the pathogenesis of AS in B27 positive subjects. 1 2 Although the evidence for an association between klebsiella and AS is conflicting,3 it is generally agreed that environmental factor(s), in addition to predisposing genetic determinants, may be important in the pathogenesis of the disease. 4 Some authors have postulated a pathogenetic role for other parasites, such as Streptococcus faecalis, Escherichia coli, Clostridium perfringens, and Epstein-Barr virus.5 6 The common denominator of these micro-organisms is their ability to behave as polyclonal B 
Results

MITOGEN RESPONSE
The unstimulated peripheral blood lymphocytes of patients with AS showed a lower thymidine uptake than the peripheral blood lymphocytes in normal controls, but the difference did not reach statistical significance. The response of peripheral blood lymphocytes to phytohaemagglutinin, concanavalin A, pokeweed mitogen, and protein A showed no difference between patients and controls. In contrast, the response to SAC was significantly higher in patients than in controls (table 1) .
To investigate the factors that might influence the peripheral blood lymphocyte response to SAC in patients with AS we considered the disease activity, the presence of HLA-B27 antigen, and environmental factors, as well as associated diseases. Table 2 summarises the results. No differences in the response to SAC were found between HLA-B27 positive and negative patients. Furthermore, the SAC response of healthy B27 negative controls did not differ from that of HLA-B27 negative and HLA-B27 positive patients' relatives and family members (table 2). In the 10 patients with AS who also had other diseases (group B) we found no difference in SAC response in comparison with the healthy controls.
Those patients with active disease showed a significantly higher response to SAC than patients with inactive disease and healthy controls. Moreover, patients with active disease showed a slightly increased percentage of circulating B lymphocytes.
The percentage of OKT3+, OKT4+, and OKT8+ cells and the OKT4/OKT8 ratio showed no differences between patients and healthy controls.
IMMUNOGLOBULIN SYNTHESIS
The IgG concentrations in the supernatants of patient peripheral blood lymphocyte cultures were similar to those found in the supernatants of controls even when the peripheral blood lymphocytes were stimulated with pokeweed mitogen (table 3) . In contrast, stimulation by SAC caused a higher production of immunoglobulin by patients' peripheral blood lymphocytes than by those of controls, but only IgM concentrations reached statistical significance (table 3) .
Discussion
These results show that the peripheral blood lymphocyte response to SAC by patients with AS is higher than that of healthy family members of patients with AS and that of HLA-B27 positive or negative healthy subjects. This hyperresponsiveness was found to be associated with the disease activity. Moreover, peripheral blood lymphocytes from all patients with AS showed an increased in vitro production of immunoglobulin only after SAC stimulation. In addition, the percentage of T cell -subpopulations was similar in patients and in controls.
The responsiveness to SAC has already been studied in association with other rheumatic
diseases. An impaired peripheral blood lymphocyte response to peptidoglycan from Staphylococcus aureus and in vitro production of rheumatoid factor were shown in patients with rheumatoid arthritis and in healthy subjects respectively.'7 18 Furthermore, an impaired response to SAC was shown in systemic lupus erythematosus and in Behcet's syndrome. '9 20 The main point raised by our study is that the increased peripheral blood lymphocyte responsiveness to SAC in patients with AS seems to be related to the disease activity. This observation is in agreement with the findings reported by others showing increased concentrations of immunoglobulin during the period of disease activity.2'
The presence of the HLA-B27 antigen does not seem to influence the peripheral blood lymphocyte responsiveness to SAC, though this observation is not in keeping with other reports about expression of immune reactivity.22 23 Similarly, environmental factors do not appear to have a role in the response to SAC as no differences were found between patients and their relatives and family members.
The lack ofan association between lymphocyte responsiveness of patients with AS and SAC, protein A, and pokeweed mitogen may be explained by the fact that pokeweed mitogen and protein A are T cell dependent polyclonal B cell activators, whereas SAC is a T cell independent B cell activator. 13 24 This finding focused our interest on B cell function. The data about B cell involvement in AS are controversial; increased proportions of B lymphocytes' and immunoblasts'2 have been reported, but there is some controversy about the technical procedures that were used."1 12 25 We used F(ab')2 reagents and found an increased number of circulating B cells in some of our patients. 28 Our data partially agree with these reports. Indeed, we found a slight increase in the spontaneous production of immunoglobulin in patients with AS, even though the response reached significance only when peripheral blood lymphocytes were stimulated with SAC.
In conclusion, the possibility exists that under particular circumstances, which remain to be clarified, the introduction of a polyclonal B cell activator into an organism may alter the host immunoreactivity. 
